METLIFE INC
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Purchases of MetLife, Inc. common stock made by or on behalf of MetLife, Inc. or its affiliates during the quarter ended March 31, 2025 are set forth below:
| Period · Total Number ofShares Purchased (1) · Average PricePaid per Share · Total Number ofSharesPurchased as Part ofPublicly AnnouncedPlans or Programs · Maximum Number (orApproximate Dollar Value)of Shares that May YetBe Purchased Under thePlans or Programs (2) | |||||
|---|---|---|---|---|---|
| January 1 — January 31, 2025 | 5,567,078 | $84.42 | 5,567,078 | $1,455,295,041 | |
| February 1 — February 28, 2025 | 5,313,977 | $83.25 | 5,312,281 | $1,013,032,930 | |
| March 1 — March 31, 2025 | 6,089,667 | $81.94 | 6,089,667 | $514,052,870 | |
| Total | 16,970,722 | 16,969,026 | |||
(1)During the periods January 1 — January 31, 2025, February 1 — February 28, 2025 and March 1 — March 31, 2025, separate account index funds purchased 0 shares, 1,696 shares and 0 shares, respectively, of MetLife, Inc. common stock on the open market in non-discretionary transactions.
(2)In May 2024, MetLife, Inc. announced that its Board of Directors authorized $3.0 billion of common stock repurchases. At March 31, 2025, MetLife, Inc. had $514 million of common stock repurchases remaining under the authorization. Neither the authorization remaining, nor the amount repurchased, reflects the applicable excise tax payable in connection with such repurchases. On April 30, 2025, MetLife, Inc. announced that its Board of Directors authorized an additional $3.0 billion of common stock repurchases. For more information on common stock repurchases, including excise tax payable in connection therewith, see Note 15 of the Notes to the Interim Condensed Consolidated Financial Statements. See also “Risk Factors — Capital Risks — We May Not be Able to Pay Dividends or Repurchase Our Stock Due to Legal and Regulatory Restrictions or Cash Buffer Needs” included in the 2024 Annual Report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.